Overview
This is a prospective randomized study compared with active control arm.
Description
This is a prospective randomized study compared with active control arm. The investigators compare the pupil size in subject when 30 minutes after administering IP (CTO0303 or active control).
Eligibility
Inclusion Criteria:
- Pediatric or adolescent subjects those who get a written consent both whom and their parents (or legally acceptable representative)
- Pediatric or adolescent subjects aged 4 to 15 years old based on date of written consent
Exclusion Criteria:
- Subjects with a history of severe systemic reaction or increased sensitivity to atropine
- Subjects with anterior segment disease that interferes with ophthalmological examination (ex. corneal scar, corneal opacity and others)
- Subjects administered mydriatic medication within 14 days prior to administration of Investigational Product
- Subjects with contact lens